DOT Name |
DOT ID |
UniProt ID |
Mode of Action |
REF |
Cytochrome P450 2C9 (CYP2C9)
|
OTGLBN29
|
CP2C9_HUMAN
|
Affects Response To Substance
|
[27] |
Arylamine N-acetyltransferase 2 (NAT2)
|
OTBPDQOY
|
ARY2_HUMAN
|
Affects Response To Substance
|
[29] |
Solute carrier family 22 member 7 (SLC22A7)
|
OTKTNH1W
|
S22A7_HUMAN
|
Decreases Activity
|
[30] |
ATP-dependent translocase ABCB1 (ABCB1)
|
OTEJROBO
|
MDR1_HUMAN
|
Increases Expression
|
[31] |
HLA class II histocompatibility antigen, DQ beta 1 chain (HLA-DQB1)
|
OTVVI3UI
|
DQB1_HUMAN
|
Increases ADR
|
[32] |
HLA class II histocompatibility antigen, DP beta 1 chain (HLA-DPB1)
|
OTW8JHU2
|
DPB1_HUMAN
|
Increases ADR
|
[32] |
Leukotriene C4 synthase (LTC4S)
|
OT3XNFJZ
|
LTC4S_HUMAN
|
Affects Response To Substance
|
[33] |
Solute carrier organic anion transporter family member 1B1 (SLCO1B1)
|
OTNEN8QK
|
SO1B1_HUMAN
|
Increases ADR
|
[34] |
Integrin beta-3 (ITGB3)
|
OTWCK1K6
|
ITB3_HUMAN
|
Decreases Response To Substance
|
[35] |
Nuclear factor NF-kappa-B p105 subunit (NFKB1)
|
OTNRRD8I
|
NFKB1_HUMAN
|
Decreases Expression
|
[36] |
Integrin alpha-IIb (ITGA2B)
|
OT4Y17PY
|
ITA2B_HUMAN
|
Decreases Expression
|
[37] |
Cyclic AMP-responsive element-binding protein 1 (CREB1)
|
OT1MDLA1
|
CREB1_HUMAN
|
Increases ADR
|
[38] |
Testis-expressed basic protein 1 (TSBP1)
|
OT5GE8IO
|
TSBP1_HUMAN
|
Increases ADR
|
[39] |
Thromboxane A2 receptor (TBXA2R)
|
OT9CIHQ5
|
TA2R_HUMAN
|
Decreases Response To Substance
|
[40] |
HLA class II histocompatibility antigen, DQ alpha 1 chain (HLA-DQA1)
|
OTC6GISG
|
DQA1_HUMAN
|
Increases ADR
|
[39] |
Collagen alpha-1(XXVI) chain (COL26A1)
|
OTMS7RNF
|
COQA1_HUMAN
|
Affects Response To Substance
|
[41] |
HLA class I histocompatibility antigen, B alpha chain (HLA-B)
|
OTNXFWY2
|
HLAB_HUMAN
|
Increases ADR
|
[42] |
Angiopoietin-related protein 4 (ANGPTL4)
|
OTQL5SPX
|
ANGL4_HUMAN
|
Increases ADR
|
[17] |
Laminin subunit alpha-1 (LAMA1)
|
OTQZMP86
|
LAMA1_HUMAN
|
Increases ADR
|
[43] |
HLA class II histocompatibility antigen, DR beta 5 chain (HLA-DRB5)
|
OTUX5TWM
|
DRB5_HUMAN
|
Increases ADR
|
[39] |
Putative glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial (GATD3)
|
OTBQRU82
|
GAL3B_HUMAN
|
Increases Expression
|
[8] |
Anoctamin-9 (ANO9)
|
OTQ2UM3M
|
ANO9_HUMAN
|
Increases Expression
|
[8] |
PH and SEC7 domain-containing protein 1 (PSD)
|
OTUZIXUZ
|
PSD1_HUMAN
|
Increases Expression
|
[8] |
Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha (PIK3C2A)
|
OTFBU4GD
|
P3C2A_HUMAN
|
Decreases Expression
|
[8] |
Protocadherin-17 (PCDH17)
|
OTRK0M05
|
PCD17_HUMAN
|
Increases Expression
|
[8] |
Aurora kinase A (AURKA)
|
OTMX0HYT
|
AURKA_HUMAN
|
Increases Expression
|
[8] |
Protein phosphatase 1 regulatory subunit 12A (PPP1R12A)
|
OT4AVU95
|
MYPT1_HUMAN
|
Decreases Expression
|
[8] |
Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 (ATP2A1)
|
OT959A3A
|
AT2A1_HUMAN
|
Increases Expression
|
[8] |
Origin recognition complex subunit 4 (ORC4)
|
OT3ACTST
|
ORC4_HUMAN
|
Increases Expression
|
[8] |
85/88 kDa calcium-independent phospholipase A2 (PLA2G6)
|
OT5FL0WU
|
PLPL9_HUMAN
|
Increases Expression
|
[8] |
Mitochondrial import inner membrane translocase subunit Tim17-B (TIMM17B)
|
OTSQGLSB
|
TI17B_HUMAN
|
Increases Expression
|
[8] |
Bromodomain-containing protein 4 (BRD4)
|
OT2Y2TCW
|
BRD4_HUMAN
|
Increases Expression
|
[8] |
Astrotactin-2 (ASTN2)
|
OTF0W2FJ
|
ASTN2_HUMAN
|
Increases Expression
|
[8] |
Hyaluronan mediated motility receptor (HMMR)
|
OT4M0JTZ
|
HMMR_HUMAN
|
Increases Expression
|
[8] |
Sperm-associated antigen 6 (SPAG6)
|
OTVVG3Q0
|
SPAG6_HUMAN
|
Increases Expression
|
[8] |
Trafficking protein particle complex subunit 6A (TRAPPC6A)
|
OT0ZRV5C
|
TPC6A_HUMAN
|
Increases Expression
|
[8] |
DNA topoisomerase 3-beta-1 (TOP3B)
|
OTNFEUOO
|
TOP3B_HUMAN
|
Increases Expression
|
[8] |
Myc proto-oncogene protein (MYC)
|
OTPV5LUK
|
MYC_HUMAN
|
Decreases Expression
|
[8] |
Salivary acidic proline-rich phosphoprotein 1/2 (PRH1)
|
OTQZ6HX0
|
PRPC_HUMAN
|
Decreases Expression
|
[8] |
Ribonuclease pancreatic (RNASE1)
|
OTKZ7CO9
|
RNAS1_HUMAN
|
Increases Expression
|
[8] |
Calmodulin-1 (CALM2)
|
OTNYA92F
|
CALM1_HUMAN
|
Increases Expression
|
[8] |
Ras-related protein Ral-B (RALB)
|
OTFH203X
|
RALB_HUMAN
|
Decreases Expression
|
[8] |
G2/mitotic-specific cyclin-B1 (CCNB1)
|
OT19S7E5
|
CCNB1_HUMAN
|
Increases Expression
|
[8] |
Atrial natriuretic peptide receptor 1 (NPR1)
|
OTRWART5
|
ANPRA_HUMAN
|
Decreases Expression
|
[8] |
Troponin I, cardiac muscle (TNNI3)
|
OT65E12V
|
TNNI3_HUMAN
|
Increases Expression
|
[8] |
L-serine dehydratase/L-threonine deaminase (SDS)
|
OT5WTJ2M
|
SDHL_HUMAN
|
Increases Expression
|
[8] |
DNA-directed RNA polymerase II subunit RPB1 (POLR2A)
|
OTHJQ1DZ
|
RPB1_HUMAN
|
Increases Expression
|
[8] |
DNA excision repair protein ERCC-5 (ERCC5)
|
OTQAKFJM
|
ERCC5_HUMAN
|
Increases Expression
|
[8] |
Neuroendocrine convertase 1 (PCSK1)
|
OTPBRJ54
|
NEC1_HUMAN
|
Decreases Expression
|
[8] |
RAC-beta serine/threonine-protein kinase (AKT2)
|
OTBB632K
|
AKT2_HUMAN
|
Increases Expression
|
[8] |
Dihydrolipoyllysine-residue succinyltransferase component of 2-oxoglutarate dehydrogenase complex, mitochondrial (DLST)
|
OTBDF9HJ
|
ODO2_HUMAN
|
Decreases Expression
|
[8] |
Signal transducer and activator of transcription 3 (STAT3)
|
OTAAGKYZ
|
STAT3_HUMAN
|
Decreases Expression
|
[8] |
Protein phosphatase inhibitor 2 (PPP1R2)
|
OTNLOUQR
|
IPP2_HUMAN
|
Decreases Expression
|
[8] |
Isoleucine--tRNA ligase, cytoplasmic (IARS1)
|
OT9WXH5N
|
SYIC_HUMAN
|
Decreases Expression
|
[8] |
Transcription initiation factor TFIID subunit 6 (TAF6)
|
OTY1Z9C4
|
TAF6_HUMAN
|
Decreases Expression
|
[8] |
Protein Tob1 (TOB1)
|
OTNW949D
|
TOB1_HUMAN
|
Decreases Expression
|
[8] |
Biotin--protein ligase (HLCS)
|
OTPDUX30
|
BPL1_HUMAN
|
Increases Expression
|
[8] |
Rho-related GTP-binding protein RhoN (RND2)
|
OT98M6UI
|
RND2_HUMAN
|
Increases Expression
|
[8] |
Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 2 (NDST2)
|
OT21PY3J
|
NDST2_HUMAN
|
Increases Expression
|
[8] |
Monocarboxylate transporter 1 (SLC16A1)
|
OTW1UTZ7
|
MOT1_HUMAN
|
Decreases Expression
|
[8] |
Puromycin-sensitive aminopeptidase (NPEPPS)
|
OTMENFXR
|
PSA_HUMAN
|
Decreases Expression
|
[8] |
Small ubiquitin-related modifier 3 (SUMO3)
|
OTTUJQJ1
|
SUMO3_HUMAN
|
Increases Expression
|
[8] |
Actin-related protein 3 (ACTR3)
|
OT05LJSH
|
ARP3_HUMAN
|
Decreases Expression
|
[8] |
26S proteasome regulatory subunit 10B (PSMC6)
|
OTG8997V
|
PRS10_HUMAN
|
Decreases Expression
|
[8] |
AP-2 complex subunit beta (AP2B1)
|
OTL6LZJ4
|
AP2B1_HUMAN
|
Decreases Expression
|
[8] |
Small ubiquitin-related modifier 1 (SUMO1)
|
OTJFD4P5
|
SUMO1_HUMAN
|
Decreases Expression
|
[8] |
Casein kinase II subunit alpha (CSNK2A1)
|
OT9T8WQM
|
CSK21_HUMAN
|
Decreases Expression
|
[8] |
Pituitary homeobox 1 (PITX1)
|
OTA0UN4C
|
PITX1_HUMAN
|
Increases Expression
|
[8] |
General transcription factor II-I (GTF2I)
|
OTUYL1TQ
|
GTF2I_HUMAN
|
Decreases Expression
|
[8] |
Cyclin-dependent kinase 3 (CDK3)
|
OT2GP6RL
|
CDK3_HUMAN
|
Increases Expression
|
[8] |
Early growth response protein 4 (EGR4)
|
OT4R3ECK
|
EGR4_HUMAN
|
Decreases Expression
|
[8] |
Voltage-dependent calcium channel gamma-1 subunit (CACNG1)
|
OT6OCR3H
|
CCG1_HUMAN
|
Decreases Expression
|
[8] |
Sodium channel subunit beta-1 (SCN1B)
|
OTGD78J3
|
SCN1B_HUMAN
|
Increases Expression
|
[8] |
V-type proton ATPase 116 kDa subunit a 3 (TCIRG1)
|
OTU1AIEW
|
VPP3_HUMAN
|
Increases Expression
|
[8] |
Phosphatidylinositol-binding clathrin assembly protein (PICALM)
|
OTQVRPMQ
|
PICAL_HUMAN
|
Decreases Expression
|
[8] |
6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 (PFKFB3)
|
OT25JBA3
|
F263_HUMAN
|
Decreases Expression
|
[8] |
TBC1 domain family member 10B (TBC1D10B)
|
OT5MVCI5
|
TB10B_HUMAN
|
Increases Expression
|
[8] |
Cyclin-J (CCNJ)
|
OTCR4WVV
|
CCNJ_HUMAN
|
Increases Expression
|
[8] |
Tensin-3 (TNS3)
|
OTPG2D8Z
|
TENS3_HUMAN
|
Increases Expression
|
[8] |
DENN domain-containing protein 5A (DENND5A)
|
OT0QNNY1
|
DEN5A_HUMAN
|
Increases Expression
|
[8] |
Kinesin-like protein KIF21A (KIF21A)
|
OT511XD9
|
KI21A_HUMAN
|
Increases Expression
|
[8] |
Calcium-activated potassium channel subunit beta-4 (KCNMB4)
|
OTYQG46B
|
KCMB4_HUMAN
|
Decreases Expression
|
[8] |
EF-hand calcium-binding domain-containing protein 4A (CRACR2B)
|
OT8L843R
|
EFC4A_HUMAN
|
Increases Expression
|
[8] |
Tumor protein p53-inducible protein 13 (TP53I13)
|
OTSUH9V8
|
P5I13_HUMAN
|
Increases Expression
|
[8] |
Basal body-orientation factor 1 (BBOF1)
|
OT88DXU7
|
BBOF1_HUMAN
|
Increases Expression
|
[8] |
Organic anion transporter 3 (SLC22A8)
|
OT8BY933
|
S22A8_HUMAN
|
Increases Expression
|
[8] |
Transient receptor potential cation channel subfamily M member 4 (TRPM4)
|
OT354X8E
|
TRPM4_HUMAN
|
Increases Expression
|
[8] |
Protocadherin Fat 3 (FAT3)
|
OT3C6H8W
|
FAT3_HUMAN
|
Increases Expression
|
[8] |
Sec1 family domain-containing protein 2 (SCFD2)
|
OTYM55ET
|
SCFD2_HUMAN
|
Increases Expression
|
[8] |
Calcyphosin-like protein (CAPSL)
|
OT5RRQ8E
|
CAPSL_HUMAN
|
Increases Expression
|
[8] |
Selenoprotein M (SELENOM)
|
OTJ7PORS
|
SELM_HUMAN
|
Increases Expression
|
[8] |
Geranylgeranyl transferase type-2 subunit alpha (RABGGTA)
|
OTYMG99C
|
PGTA_HUMAN
|
Increases Expression
|
[8] |
CREB-binding protein (CREBBP)
|
OTPA4QGM
|
CBP_HUMAN
|
Increases Expression
|
[8] |
Ribonuclease K6 (RNASE6)
|
OTJIK1RY
|
RNAS6_HUMAN
|
Increases Expression
|
[8] |
CAP-Gly domain-containing linker protein 3 (CLIP3)
|
OTGJEGIB
|
CLIP3_HUMAN
|
Increases Expression
|
[8] |
Receptor expression-enhancing protein 6 (REEP6)
|
OTY4FPO8
|
REEP6_HUMAN
|
Increases Expression
|
[8] |
Histone-lysine N-methyltransferase EHMT2 (EHMT2)
|
OTC4DWB6
|
EHMT2_HUMAN
|
Increases Expression
|
[8] |
Arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 3 (ACAP3)
|
OTOE9OYV
|
ACAP3_HUMAN
|
Increases Expression
|
[8] |
Kinesin-like protein KIF20B (KIF20B)
|
OTS68AHH
|
KI20B_HUMAN
|
Decreases Expression
|
[8] |
Translin-associated protein X (TSNAX)
|
OTZ9SGWB
|
TSNAX_HUMAN
|
Increases Expression
|
[8] |
C-C motif chemokine 19 (CCL19)
|
OTQ2UJMH
|
CCL19_HUMAN
|
Increases Expression
|
[8] |
Copine-1 (CPNE1)
|
OTH5YKSL
|
CPNE1_HUMAN
|
Increases Expression
|
[8] |
Allograft inflammatory factor 1-like (AIF1L)
|
OTDEOB80
|
AIF1L_HUMAN
|
Increases Expression
|
[8] |
Glucose-6-phosphatase 3 (G6PC3)
|
OTH7BWNL
|
G6PC3_HUMAN
|
Increases Expression
|
[8] |
Bublin coiled-coil protein (BBLN)
|
OTUMVEWE
|
BBLN_HUMAN
|
Increases Expression
|
[8] |
Transmembrane emp24 domain-containing protein 9 (TMED9)
|
OTYGAQS0
|
TMED9_HUMAN
|
Increases Expression
|
[8] |
Intraflagellar transport protein 27 homolog (IFT27)
|
OT3NY6O6
|
IFT27_HUMAN
|
Increases Expression
|
[8] |
Cyclin-dependent kinase 19 (CDK19)
|
OTVMM0CP
|
CDK19_HUMAN
|
Increases Expression
|
[8] |
E3 ubiquitin-protein ligase RNF26 (RNF26)
|
OTPXA60S
|
RNF26_HUMAN
|
Increases Expression
|
[8] |
tRNA dimethylallyltransferase (TRIT1)
|
OTCU9FS5
|
MOD5_HUMAN
|
Increases Expression
|
[8] |
T-lymphocyte surface antigen Ly-9 (LY9)
|
OT1PKGDI
|
LY9_HUMAN
|
Increases Expression
|
[8] |
Striatin-4 (STRN4)
|
OTHK2ZN6
|
STRN4_HUMAN
|
Increases Expression
|
[8] |
Structural maintenance of chromosomes protein 4 (SMC4)
|
OTEJE6AG
|
SMC4_HUMAN
|
Decreases Expression
|
[8] |
ATP-dependent RNA helicase DDX18 (DDX18)
|
OTKB9C3S
|
DDX18_HUMAN
|
Decreases Expression
|
[8] |
Very long chain fatty acid elongase 5 (ELOVL5)
|
OT375W1Z
|
ELOV5_HUMAN
|
Decreases Expression
|
[8] |
Programmed cell death 1 ligand 1 (CD274)
|
OTJ0VFDL
|
PD1L1_HUMAN
|
Increases Expression
|
[8] |
Tropomodulin-4 (TMOD4)
|
OTXLGJ4R
|
TMOD4_HUMAN
|
Increases Expression
|
[8] |
SUN domain-containing protein 2 (SUN2)
|
OT2IQJUC
|
SUN2_HUMAN
|
Increases Expression
|
[8] |
TNF receptor-associated factor 6 (TRAF6)
|
OTA5GO5K
|
TRAF6_HUMAN
|
Increases Expression
|
[8] |
Solute carrier family 22 member 6 (SLC22A6)
|
OTKRCBVM
|
S22A6_HUMAN
|
Decreases Activity
|
[30] |
Organic anion transporter 7 (SLC22A9)
|
OTO4BJCC
|
S22A9_HUMAN
|
Decreases Activity
|
[30] |
Solute carrier family 22 member 11 (SLC22A11)
|
OTAJLNJZ
|
S22AB_HUMAN
|
Decreases Activity
|
[30] |
Prostaglandin G/H synthase 2 (PTGS2)
|
OT75U9M4
|
PGH2_HUMAN
|
Decreases Degradation
|
[44] |
Mitogen-activated protein kinase 14 (MAPK14)
|
OT5TCO3O
|
MK14_HUMAN
|
Increases Phosphorylation
|
[44] |
2'-5'-oligoadenylate synthase 1 (OAS1)
|
OT8ZLOCY
|
OAS1_HUMAN
|
Increases Expression
|
[36] |
Interleukin-1 beta (IL1B)
|
OT0DWXXB
|
IL1B_HUMAN
|
Increases Expression
|
[36] |
Transcription factor Jun (JUN)
|
OTCYBO6X
|
JUN_HUMAN
|
Increases Expression
|
[36] |
Endoplasmic reticulum chaperone BiP (HSPA5)
|
OTFUIRAO
|
BIP_HUMAN
|
Decreases Expression
|
[36] |
Ornithine decarboxylase (ODC1)
|
OTNDAGRR
|
DCOR_HUMAN
|
Increases Expression
|
[36] |
Ezrin (EZR)
|
OTHBPF1Z
|
EZRI_HUMAN
|
Decreases Expression
|
[36] |
Integrin beta-4 (ITGB4)
|
OT28UK84
|
ITB4_HUMAN
|
Decreases Expression
|
[36] |
Transcription factor JunD (JUND)
|
OTNKACJD
|
JUND_HUMAN
|
Decreases Expression
|
[36] |
HLA class I histocompatibility antigen, alpha chain G (HLA-G)
|
OTMLK1KN
|
HLAG_HUMAN
|
Decreases Expression
|
[36] |
G1/S-specific cyclin-D3 (CCND3)
|
OTNKPQ22
|
CCND3_HUMAN
|
Decreases Expression
|
[36] |
Leukocyte elastase inhibitor (SERPINB1)
|
OT5RDUFO
|
ILEU_HUMAN
|
Decreases Expression
|
[36] |
Prohibitin 1 (PHB1)
|
OTZNXYS2
|
PHB1_HUMAN
|
Decreases Expression
|
[36] |
DNA damage-inducible transcript 3 protein (DDIT3)
|
OTI8YKKE
|
DDIT3_HUMAN
|
Increases Expression
|
[36] |
Cell division control protein 42 homolog (CDC42)
|
OT5QBC5M
|
CDC42_HUMAN
|
Decreases Expression
|
[36] |
Cyclin-dependent kinases regulatory subunit 1 (CKS1B)
|
OTNUPLUJ
|
CKS1_HUMAN
|
Increases Expression
|
[36] |
Small ribosomal subunit protein uS9 (RPS16)
|
OTVGZOB5
|
RS16_HUMAN
|
Increases Expression
|
[36] |
Ras-related C3 botulinum toxin substrate 1 (RAC1)
|
OTKRO61U
|
RAC1_HUMAN
|
Increases Expression
|
[36] |
Elongation factor 1-alpha 1 (EEF1A1)
|
OT00THXS
|
EF1A1_HUMAN
|
Increases Expression
|
[36] |
Glutathione S-transferase omega-1 (GSTO1)
|
OTUJ93MN
|
GSTO1_HUMAN
|
Decreases Expression
|
[36] |
Bleomycin hydrolase (BLMH)
|
OT2QPWQJ
|
BLMH_HUMAN
|
Decreases Expression
|
[36] |
Protein tyrosine phosphatase type IVA 1 (PTP4A1)
|
OTK0NFXJ
|
TP4A1_HUMAN
|
Increases Expression
|
[36] |
Growth/differentiation factor 15 (GDF15)
|
OTWQN50N
|
GDF15_HUMAN
|
Increases Expression
|
[36] |
Charged multivesicular body protein 1a (CHMP1A)
|
OTVQ5UWX
|
CHM1A_HUMAN
|
Decreases Expression
|
[36] |
Heterogeneous nuclear ribonucleoprotein D-like (HNRNPDL)
|
OTB3BFCV
|
HNRDL_HUMAN
|
Decreases Expression
|
[9] |
Nucleoside diphosphate kinase 6 (NME6)
|
OTJNKOFA
|
NDK6_HUMAN
|
Increases Expression
|
[9] |
Epidermal growth factor receptor (EGFR)
|
OTAPLO1S
|
EGFR_HUMAN
|
Increases Expression
|
[9] |
Alpha-1-antichymotrypsin (SERPINA3)
|
OT9BP2S0
|
AACT_HUMAN
|
Decreases Expression
|
[9] |
Cystatin-A (CSTA)
|
OT1K68KE
|
CYTA_HUMAN
|
Increases Expression
|
[9] |
Collagen alpha-1(III) chain (COL3A1)
|
OTT1EMLM
|
CO3A1_HUMAN
|
Decreases Expression
|
[9] |
Plasminogen activator inhibitor 2 (SERPINB2)
|
OT72QLZB
|
PAI2_HUMAN
|
Decreases Expression
|
[9] |
Heat shock 70 kDa protein 1A (HSPA1A)
|
OTKGIE76
|
HS71A_HUMAN
|
Increases Expression
|
[9] |
Beta-1,4-galactosyltransferase 1 (B4GALT1)
|
OTBCXEK7
|
B4GT1_HUMAN
|
Increases Expression
|
[9] |
Platelet endothelial cell adhesion molecule (PECAM1)
|
OTXOM4D9
|
PECA1_HUMAN
|
Decreases Expression
|
[9] |
Tyrosine-protein kinase Fer (FER)
|
OT9JR7AE
|
FER_HUMAN
|
Decreases Expression
|
[9] |
Pulmonary surfactant-associated protein D (SFTPD)
|
OTNKPDJC
|
SFTPD_HUMAN
|
Increases Expression
|
[9] |
Small ribosomal subunit protein eS19 (RPS19)
|
OTBKGP48
|
RS19_HUMAN
|
Increases Expression
|
[9] |
Cell surface glycoprotein MUC18 (MCAM)
|
OTT8XKGE
|
MUC18_HUMAN
|
Increases Expression
|
[9] |
RNA-binding protein FXR2 (FXR2)
|
OTQX7ATF
|
FXR2_HUMAN
|
Decreases Expression
|
[9] |
Ras-related protein Rab-2A (RAB2A)
|
OT6SK83U
|
RAB2A_HUMAN
|
Increases Expression
|
[9] |
Beta-2-microglobulin (B2M)
|
OTDWN6NX
|
B2MG_HUMAN
|
Increases Expression
|
[9] |
Hemoglobin subunit gamma-2 (HBG2)
|
OT4J48JJ
|
HBG2_HUMAN
|
Increases Expression
|
[9] |
Butyrophilin subfamily 3 member A2 (BTN3A2)
|
OT3DIBU3
|
BT3A2_HUMAN
|
Decreases Expression
|
[9] |
Sushi repeat-containing protein SRPX (SRPX)
|
OT5B9LXS
|
SRPX_HUMAN
|
Decreases Expression
|
[9] |
Metastasis-associated protein MTA1 (MTA1)
|
OTBHW3S9
|
MTA1_HUMAN
|
Increases Expression
|
[9] |
Histone deacetylase 1 (HDAC1)
|
OTQDNOXZ
|
HDAC1_HUMAN
|
Increases Expression
|
[9] |
Ras GTPase-activating-like protein IQGAP2 (IQGAP2)
|
OTX2UA7P
|
IQGA2_HUMAN
|
Increases Expression
|
[9] |
Spectrin alpha chain, non-erythrocytic 1 (SPTAN1)
|
OT6VY3A3
|
SPTN1_HUMAN
|
Decreases Expression
|
[9] |
MOB kinase activator 2 (MOB2)
|
OTMBE0NS
|
MOB2_HUMAN
|
Increases Expression
|
[9] |
Centromere protein S (CENPS)
|
OTZ4J391
|
CENPS_HUMAN
|
Increases Expression
|
[9] |
LIM domain only protein 7 (LMO7)
|
OTDLY6TC
|
LMO7_HUMAN
|
Increases Expression
|
[9] |
Neuronal cell adhesion molecule (NRCAM)
|
OT80HHQ2
|
NRCAM_HUMAN
|
Decreases Expression
|
[9] |
N-alpha-acetyltransferase 38, NatC auxiliary subunit (NAA38)
|
OTI8VWK3
|
LSMD1_HUMAN
|
Increases Expression
|
[9] |
A disintegrin and metalloproteinase with thrombospondin motifs 1 (ADAMTS1)
|
OTTLJH8W
|
ATS1_HUMAN
|
Decreases Expression
|
[9] |
Translocon-associated protein subunit gamma (SSR3)
|
OTJQP0IZ
|
SSRG_HUMAN
|
Increases Expression
|
[9] |
Cytosolic Fe-S cluster assembly factor NUBP2 (NUBP2)
|
OTYOTM2B
|
NUBP2_HUMAN
|
Decreases Expression
|
[9] |
Pseudouridylate synthase 1 homolog (PUS1)
|
OTS2DQ0N
|
PUS1_HUMAN
|
Increases Expression
|
[9] |
26S proteasome non-ATPase regulatory subunit 12 (PSMD12)
|
OTWICA51
|
PSD12_HUMAN
|
Increases Expression
|
[10] |
Importin subunit alpha-4 (KPNA3)
|
OTLI3TM2
|
IMA4_HUMAN
|
Increases Expression
|
[10] |
Chromodomain-helicase-DNA-binding protein 2 (CHD2)
|
OTRKL6YC
|
CHD2_HUMAN
|
Increases Expression
|
[10] |
Insulin-induced gene 1 protein (INSIG1)
|
OTZF5X1D
|
INSI1_HUMAN
|
Increases Expression
|
[10] |
E3 ubiquitin-protein ligase SIAH2 (SIAH2)
|
OTKED2XN
|
SIAH2_HUMAN
|
Decreases Expression
|
[10] |
Tumor protein D54 (TPD52L2)
|
OTTOG0NK
|
TPD54_HUMAN
|
Decreases Expression
|
[10] |
BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like (BNIP3L)
|
OTJKOMXE
|
BNI3L_HUMAN
|
Increases Expression
|
[10] |
GDNF family receptor alpha-3 (GFRA3)
|
OT07XAZF
|
GFRA3_HUMAN
|
Increases Expression
|
[10] |
Tetraspanin-3 (TSPAN3)
|
OT7WS6ZI
|
TSN3_HUMAN
|
Decreases Expression
|
[10] |
F-box-like/WD repeat-containing protein TBL1X (TBL1X)
|
OTXQ51E0
|
TBL1X_HUMAN
|
Decreases Expression
|
[10] |
Breast cancer anti-estrogen resistance protein 3 (BCAR3)
|
OTPJ17M8
|
BCAR3_HUMAN
|
Increases Expression
|
[10] |
PRA1 family protein 3 (ARL6IP5)
|
OTYZ6BEQ
|
PRAF3_HUMAN
|
Increases Expression
|
[10] |
Gamma-aminobutyric acid receptor-associated protein (GABARAP)
|
OTAQUX6E
|
GBRAP_HUMAN
|
Decreases Expression
|
[10] |
Histone acetyltransferase KAT7 (KAT7)
|
OTUN98IC
|
KAT7_HUMAN
|
Decreases Expression
|
[10] |
STAM-binding protein (STAMBP)
|
OTOT2OXM
|
STABP_HUMAN
|
Increases Expression
|
[10] |
Mitogen-activated protein kinase kinase kinase kinase 4 (MAP4K4)
|
OTBMJUOC
|
M4K4_HUMAN
|
Decreases Expression
|
[10] |
Transforming growth factor beta-1 proprotein (TGFB1)
|
OTV5XHVH
|
TGFB1_HUMAN
|
Decreases Expression
|
[10] |
T-cell surface glycoprotein CD8 alpha chain (CD8A)
|
OTDWQJXK
|
CD8A_HUMAN
|
Decreases Expression
|
[10] |
Antileukoproteinase (SLPI)
|
OTUNFUU8
|
SLPI_HUMAN
|
Decreases Expression
|
[10] |
Fructose-bisphosphate aldolase A (ALDOA)
|
OTWRFTIB
|
ALDOA_HUMAN
|
Decreases Expression
|
[10] |
HLA class II histocompatibility antigen gamma chain (CD74)
|
OTO16X4Q
|
HG2A_HUMAN
|
Decreases Expression
|
[10] |
Argininosuccinate lyase (ASL)
|
OTI2NGQR
|
ARLY_HUMAN
|
Decreases Expression
|
[10] |
Calpain small subunit 1 (CAPNS1)
|
OT95EBBD
|
CPNS1_HUMAN
|
Decreases Expression
|
[10] |
Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 1 (RPN1)
|
OTEG4KU9
|
RPN1_HUMAN
|
Decreases Expression
|
[10] |
Tyrosine-protein kinase Lck (LCK)
|
OT883FG9
|
LCK_HUMAN
|
Decreases Expression
|
[10] |
Profilin-1 (PFN1)
|
OTHTGA1H
|
PROF1_HUMAN
|
Decreases Expression
|
[10] |
Adenine phosphoribosyltransferase (APRT)
|
OT5ZUKVF
|
APT_HUMAN
|
Decreases Expression
|
[10] |
Tyrosine-protein kinase Lyn (LYN)
|
OTP686K2
|
LYN_HUMAN
|
Increases Expression
|
[10] |
Thrombospondin-1 (THBS1)
|
OT0ECWK3
|
TSP1_HUMAN
|
Increases Expression
|
[10] |
Tyrosine-protein kinase HCK (HCK)
|
OTRL6OSI
|
HCK_HUMAN
|
Decreases Expression
|
[10] |
Integrin alpha-5 (ITGA5)
|
OT3RCI67
|
ITA5_HUMAN
|
Decreases Expression
|
[10] |
Tyrosine-protein kinase Fgr (FGR)
|
OTCUYU9F
|
FGR_HUMAN
|
Decreases Expression
|
[10] |
Furin (FURIN)
|
OTM2665Z
|
FURIN_HUMAN
|
Decreases Expression
|
[10] |
Interleukin-8 (CXCL8)
|
OTS7T5VH
|
IL8_HUMAN
|
Increases Expression
|
[10] |
Interferon regulatory factor 1 (IRF1)
|
OT43DI6J
|
IRF1_HUMAN
|
Increases Expression
|
[10] |
Cation-independent mannose-6-phosphate receptor (IGF2R)
|
OTDXPQVX
|
MPRI_HUMAN
|
Increases Expression
|
[10] |
Gamma-interferon-inducible lysosomal thiol reductase (IFI30)
|
OT9DERT1
|
GILT_HUMAN
|
Decreases Expression
|
[10] |
Hematopoietic lineage cell-specific protein (HCLS1)
|
OTX7WGYN
|
HCLS1_HUMAN
|
Decreases Expression
|
[10] |
Matrix metalloproteinase-9 (MMP9)
|
OTB2QDAV
|
MMP9_HUMAN
|
Decreases Expression
|
[10] |
Interleukin-2 receptor subunit beta (IL2RB)
|
OT6M0F70
|
IL2RB_HUMAN
|
Increases Expression
|
[10] |
Metalloproteinase inhibitor 2 (TIMP2)
|
OT8S1RRP
|
TIMP2_HUMAN
|
Decreases Expression
|
[10] |
NADPH--cytochrome P450 reductase (POR)
|
OTVIDOCH
|
NCPR_HUMAN
|
Decreases Expression
|
[10] |
Interleukin-7 receptor subunit alpha (IL7R)
|
OTBMFLQQ
|
IL7RA_HUMAN
|
Increases Expression
|
[10] |
Calpain-2 catalytic subunit (CAPN2)
|
OTIAPE5J
|
CAN2_HUMAN
|
Increases Expression
|
[10] |
Probable ATP-dependent RNA helicase DDX5 (DDX5)
|
OTLS124U
|
DDX5_HUMAN
|
Increases Expression
|
[10] |
Cyclic AMP-dependent transcription factor ATF-4 (ATF4)
|
OTRFV19J
|
ATF4_HUMAN
|
Decreases Expression
|
[10] |
E3 ubiquitin-protein ligase TRIM21 (TRIM21)
|
OTA4UJCF
|
RO52_HUMAN
|
Decreases Expression
|
[10] |
Transcription factor E3 (TFE3)
|
OTM99ZWH
|
TFE3_HUMAN
|
Decreases Expression
|
[10] |
Eukaryotic translation initiation factor 2 subunit 2 (EIF2S2)
|
OTXF0B09
|
IF2B_HUMAN
|
Increases Expression
|
[10] |
Interferon-induced GTP-binding protein Mx1 (MX1)
|
OT6X8G5T
|
MX1_HUMAN
|
Decreases Expression
|
[10] |
fMet-Leu-Phe receptor (FPR1)
|
OTFF9I6W
|
FPR1_HUMAN
|
Decreases Expression
|
[10] |
Granulysin (GNLY)
|
OTZJKA8C
|
GNLY_HUMAN
|
Decreases Expression
|
[10] |
Peptidyl-prolyl cis-trans isomerase B (PPIB)
|
OTLPH6KN
|
PPIB_HUMAN
|
Decreases Expression
|
[10] |
Calnexin (CANX)
|
OTYP1F6J
|
CALX_HUMAN
|
Decreases Expression
|
[10] |
T-cell differentiation antigen CD6 (CD6)
|
OTOS044E
|
CD6_HUMAN
|
Decreases Expression
|
[10] |
High affinity immunoglobulin epsilon receptor subunit gamma (FCER1G)
|
OTBZBL9Y
|
FCERG_HUMAN
|
Decreases Expression
|
[10] |
Syndecan-4 (SDC4)
|
OTKUVUGZ
|
SDC4_HUMAN
|
Decreases Expression
|
[10] |
Cytokine receptor common subunit gamma (IL2RG)
|
OTRZ3OMY
|
IL2RG_HUMAN
|
Decreases Expression
|
[10] |
Protein S100-A11 (S100A11)
|
OTI57KDN
|
S10AB_HUMAN
|
Decreases Expression
|
[10] |
Intercellular adhesion molecule 3 (ICAM3)
|
OTTZ5A5D
|
ICAM3_HUMAN
|
Decreases Expression
|
[10] |
Protein EVI2B (EVI2B)
|
OT98X1OE
|
EVI2B_HUMAN
|
Increases Expression
|
[10] |
Protein DEK (DEK)
|
OTYCJ5H6
|
DEK_HUMAN
|
Increases Expression
|
[10] |
Dual specificity mitogen-activated protein kinase kinase 2 (MAP2K2)
|
OTUE7Z91
|
MP2K2_HUMAN
|
Decreases Expression
|
[10] |
F-actin-capping protein subunit alpha-2 (CAPZA2)
|
OTHAO4V2
|
CAZA2_HUMAN
|
Increases Expression
|
[10] |
Prolyl endopeptidase (PREP)
|
OTSJZBB5
|
PPCE_HUMAN
|
Decreases Expression
|
[10] |
Paxillin (PXN)
|
OTVMMUOF
|
PAXI_HUMAN
|
Decreases Expression
|
[10] |
Large ribosomal subunit protein eL34 (RPL34)
|
OT0U9VMQ
|
RL34_HUMAN
|
Increases Expression
|
[10] |
Dual specificity protein kinase CLK2 (CLK2)
|
OT1CRSY2
|
CLK2_HUMAN
|
Decreases Expression
|
[10] |
Dual specificity protein kinase CLK3 (CLK3)
|
OT74DJ3J
|
CLK3_HUMAN
|
Decreases Expression
|
[10] |
Death-associated protein 1 (DAP)
|
OT5YLL7E
|
DAP1_HUMAN
|
Decreases Expression
|
[10] |
Signal transducer and activator of transcription 5B (STAT5B)
|
OTZVPEBT
|
STA5B_HUMAN
|
Decreases Expression
|
[10] |
Hepatoma-derived growth factor (HDGF)
|
OT16PTBC
|
HDGF_HUMAN
|
Decreases Expression
|
[10] |
F-actin-capping protein subunit alpha-1 (CAPZA1)
|
OTAXA66U
|
CAZA1_HUMAN
|
Increases Expression
|
[10] |
Protein FosB (FOSB)
|
OTW6C05J
|
FOSB_HUMAN
|
Decreases Expression
|
[10] |
Protein SEC13 homolog (SEC13)
|
OTSR4WWM
|
SEC13_HUMAN
|
Decreases Expression
|
[10] |
cAMP-regulated phosphoprotein 19 (ARPP19)
|
OTZS3IT6
|
ARP19_HUMAN
|
Increases Expression
|
[10] |
ATP synthase subunit epsilon, mitochondrial (ATP5F1E)
|
OTMPLAIS
|
ATP5E_HUMAN
|
Increases Expression
|
[10] |
Histone deacetylase 4 (HDAC4)
|
OTQNGD32
|
HDAC4_HUMAN
|
Increases Expression
|
[10] |
Serine/threonine-protein phosphatase 4 catalytic subunit (PPP4C)
|
OT4B0TNV
|
PP4C_HUMAN
|
Decreases Expression
|
[10] |
V-type proton ATPase subunit d 1 (ATP6V0D1)
|
OT9GU2NW
|
VA0D1_HUMAN
|
Decreases Expression
|
[10] |
Protein BTG1 (BTG1)
|
OTVJ2CDM
|
BTG1_HUMAN
|
Increases Expression
|
[10] |
Thymosin beta-4 (TMSB4X)
|
OT9HPLP3
|
TYB4_HUMAN
|
Increases Expression
|
[10] |
Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-2 (GNB2)
|
OT3JPRCQ
|
GBB2_HUMAN
|
Decreases Expression
|
[10] |
Ubiquitin-ribosomal protein eS31 fusion protein (RPS27A)
|
OTIIGGZ2
|
RS27A_HUMAN
|
Increases Expression
|
[10] |
Transformer-2 protein homolog beta (TRA2B)
|
OTZYQW52
|
TRA2B_HUMAN
|
Increases Expression
|
[10] |
Rho-related GTP-binding protein RhoG (RHOG)
|
OTJ7J1WA
|
RHOG_HUMAN
|
Decreases Expression
|
[10] |
Heterogeneous nuclear ribonucleoprotein U (HNRNPU)
|
OTLQN1E2
|
HNRPU_HUMAN
|
Increases Expression
|
[10] |
Interferon regulatory factor 9 (IRF9)
|
OTK4MYQJ
|
IRF9_HUMAN
|
Decreases Expression
|
[10] |
Collagen alpha-1(VII) chain (COL7A1)
|
OT3MIRZJ
|
CO7A1_HUMAN
|
Decreases Expression
|
[10] |
Killer cell lectin-like receptor subfamily B member 1 (KLRB1)
|
OTQ2959Y
|
KLRB1_HUMAN
|
Increases Expression
|
[10] |
Protein flightless-1 homolog (FLII)
|
OT7G9JG6
|
FLII_HUMAN
|
Decreases Expression
|
[10] |
Dual specificity mitogen-activated protein kinase kinase 5 (MAP2K5)
|
OT6T408U
|
MP2K5_HUMAN
|
Decreases Expression
|
[10] |
Integrin-linked protein kinase (ILK)
|
OTYG2FD1
|
ILK_HUMAN
|
Decreases Expression
|
[10] |
Peptidyl-prolyl cis-trans isomerase G (PPIG)
|
OTZ8BTTM
|
PPIG_HUMAN
|
Increases Expression
|
[10] |
Phorbol-12-myristate-13-acetate-induced protein 1 (PMAIP1)
|
OTXEE550
|
APR_HUMAN
|
Increases Expression
|
[10] |
Flotillin-2 (FLOT2)
|
OTZ0QR5L
|
FLOT2_HUMAN
|
Decreases Expression
|
[10] |
Protein tyrosine phosphatase receptor type C-associated protein (PTPRCAP)
|
OT2YERNV
|
PTCA_HUMAN
|
Decreases Expression
|
[10] |
Poly(rC)-binding protein 1 (PCBP1)
|
OTHN0TD7
|
PCBP1_HUMAN
|
Decreases Expression
|
[10] |
Homeobox protein TGIF1 (TGIF1)
|
OTN9VHAG
|
TGIF1_HUMAN
|
Decreases Expression
|
[10] |
Myeloid leukemia factor 2 (MLF2)
|
OTU3B4WU
|
MLF2_HUMAN
|
Decreases Expression
|
[10] |
Hsp90 co-chaperone Cdc37 (CDC37)
|
OTYDT4A7
|
CDC37_HUMAN
|
Decreases Expression
|
[10] |
Proprotein convertase subtilisin/kexin type 7 (PCSK7)
|
OTVR1K2Y
|
PCSK7_HUMAN
|
Decreases Expression
|
[10] |
Protein NKG7 (NKG7)
|
OTXDD006
|
NKG7_HUMAN
|
Decreases Expression
|
[10] |
MAP kinase-activated protein kinase 3 (MAPKAPK3)
|
OT7IWJNI
|
MAPK3_HUMAN
|
Decreases Expression
|
[10] |
Guanylate kinase (GUK1)
|
OTLI0HRU
|
KGUA_HUMAN
|
Decreases Expression
|
[10] |
All-trans retinoic acid-induced differentiation factor (ATRAID)
|
OTOHZG1O
|
ARAID_HUMAN
|
Decreases Expression
|
[10] |
eIF5-mimic protein 2 (BZW1)
|
OT4GUFIG
|
5MP2_HUMAN
|
Increases Expression
|
[10] |
F-box only protein 11 (FBXO11)
|
OTGWF3Q2
|
FBX11_HUMAN
|
Increases Expression
|
[10] |
Leukocyte immunoglobulin-like receptor subfamily A member 2 (LILRA2)
|
OT1O2K47
|
LIRA2_HUMAN
|
Decreases Expression
|
[10] |
Protein odd-skipped-related 1 (OSR1)
|
OTB19LEQ
|
OSR1_HUMAN
|
Increases Expression
|
[10] |
Pumilio homolog 2 (PUM2)
|
OT2H7NXV
|
PUM2_HUMAN
|
Increases Expression
|
[10] |
PEST proteolytic signal-containing nuclear protein (PCNP)
|
OTJUQ122
|
PCNP_HUMAN
|
Increases Expression
|
[10] |
MAP kinase-activating death domain protein (MADD)
|
OTUFYVGG
|
MADD_HUMAN
|
Decreases Expression
|
[10] |
Ubiquitin carboxyl-terminal hydrolase BAP1 (BAP1)
|
OTS8G0EN
|
BAP1_HUMAN
|
Decreases Expression
|
[10] |
Nuclear receptor subfamily 4 group A member 3 (NR4A3)
|
OTPBE9R1
|
NR4A3_HUMAN
|
Increases Expression
|
[10] |
Protein TFG (TFG)
|
OT2KJENI
|
TFG_HUMAN
|
Increases Expression
|
[10] |
Ninjurin-1 (NINJ1)
|
OTLRZ1EU
|
NINJ1_HUMAN
|
Decreases Expression
|
[10] |
Erbin (ERBIN)
|
OTNWTUA8
|
ERBIN_HUMAN
|
Increases Expression
|
[10] |
Granulocyte colony-stimulating factor receptor (CSF3R)
|
OTXRAY6X
|
CSF3R_HUMAN
|
Decreases Expression
|
[10] |
V-type proton ATPase 21 kDa proteolipid subunit c'' (ATP6V0B)
|
OT8GTI1V
|
VATO_HUMAN
|
Decreases Expression
|
[10] |
ETS-related transcription factor Elf-4 (ELF4)
|
OT167PR5
|
ELF4_HUMAN
|
Decreases Expression
|
[10] |
Prohibitin-2 (PHB2)
|
OTCAX3AW
|
PHB2_HUMAN
|
Decreases Expression
|
[10] |
Heterogeneous nuclear ribonucleoprotein U-like protein 1 (HNRNPUL1)
|
OTJP4U7K
|
HNRL1_HUMAN
|
Decreases Expression
|
[10] |
Programmed cell death protein 10 (PDCD10)
|
OTCHJTSF
|
PDC10_HUMAN
|
Increases Expression
|
[10] |
GTP-binding protein 2 (GTPBP2)
|
OTOJ1KUA
|
GTPB2_HUMAN
|
Decreases Expression
|
[10] |
NF-kappa-B inhibitor zeta (NFKBIZ)
|
OTU728KS
|
IKBZ_HUMAN
|
Increases Expression
|
[10] |
Large ribosomal subunit protein mL46 (MRPL46)
|
OTMQ2A0Q
|
RM46_HUMAN
|
Increases Expression
|
[10] |
Growth hormone-inducible transmembrane protein (GHITM)
|
OTBPNIC0
|
GHITM_HUMAN
|
Increases Expression
|
[10] |
E3 ubiquitin-protein ligase SMURF2 (SMURF2)
|
OT3TRVL7
|
SMUF2_HUMAN
|
Increases Expression
|
[10] |
Mediator of RNA polymerase II transcription subunit 4 (MED4)
|
OTALFN4S
|
MED4_HUMAN
|
Increases Expression
|
[10] |
PDZ and LIM domain protein 7 (PDLIM7)
|
OTAZVODU
|
PDLI7_HUMAN
|
Decreases Expression
|
[10] |
Phosphoprotein associated with glycosphingolipid-enriched microdomains 1 (PAG1)
|
OTFOJUIQ
|
PHAG1_HUMAN
|
Increases Expression
|
[10] |
Phosphatidylinositol 4-kinase beta (PI4KB)
|
OTI9UQSU
|
PI4KB_HUMAN
|
Decreases Expression
|
[10] |
Peflin (PEF1)
|
OTY24CUW
|
PEF1_HUMAN
|
Decreases Expression
|
[10] |
Lysine-specific demethylase 5B (KDM5B)
|
OT5DL94T
|
KDM5B_HUMAN
|
Decreases Expression
|
[10] |
Tyrosine-protein kinase BAZ1B (BAZ1B)
|
OTD5KR2J
|
BAZ1B_HUMAN
|
Decreases Expression
|
[10] |
F-box/LRR-repeat protein 3 (FBXL3)
|
OTDQ1QKV
|
FBXL3_HUMAN
|
Increases Expression
|
[10] |
Apoptotic chromatin condensation inducer in the nucleus (ACIN1)
|
OTK81F92
|
ACINU_HUMAN
|
Decreases Expression
|
[10] |
Transforming acidic coiled-coil-containing protein 3 (TACC3)
|
OTRNEZTA
|
TACC3_HUMAN
|
Decreases Expression
|
[10] |
Aminopeptidase N (ANPEP)
|
OTP3WYFD
|
AMPN_HUMAN
|
Increases Expression
|
[45] |
Diamine acetyltransferase 1 (SAT1)
|
OT52AU22
|
SAT1_HUMAN
|
Increases Expression
|
[46] |
Nitric oxide synthase, inducible (NOS2)
|
OTKKIOJ1
|
NOS2_HUMAN
|
Increases Expression
|
[47] |
Apolipoprotein A-I (APOA1)
|
OT5THARI
|
APOA1_HUMAN
|
Increases Expression
|
[48] |
Serum paraoxonase/arylesterase 1 (PON1)
|
OTD0Z2XO
|
PON1_HUMAN
|
Increases Expression
|
[48] |
Aryl hydrocarbon receptor (AHR)
|
OTFE4EYE
|
AHR_HUMAN
|
Increases Expression
|
[48] |
Aldo-keto reductase family 1 member C3 (AKR1C3)
|
OTU2SXBA
|
AK1C3_HUMAN
|
Decreases Activity
|
[49] |
Aldo-keto reductase family 1 member C2 (AKR1C2)
|
OTQ2XMO3
|
AK1C2_HUMAN
|
Decreases Activity
|
[49] |
Aldo-keto reductase family 1 member C1 (AKR1C1)
|
OTQKR4CM
|
AK1C1_HUMAN
|
Decreases Activity
|
[49] |
NAD(P)H dehydrogenase 1 (NQO1)
|
OTZGGIVK
|
NQO1_HUMAN
|
Increases Activity
|
[50] |
Prostaglandin E synthase (PTGES)
|
OTB7YQFU
|
PTGES_HUMAN
|
Decreases Expression
|
[51] |
Apoptotic protease-activating factor 1 (APAF1)
|
OTJWIVY0
|
APAF_HUMAN
|
Increases Expression
|
[52] |
Telomerase reverse transcriptase (TERT)
|
OT085VVA
|
TERT_HUMAN
|
Increases Expression
|
[52] |
Tumor necrosis factor receptor superfamily member 10B (TNFRSF10B)
|
OTA1CPBV
|
TR10B_HUMAN
|
Increases Expression
|
[52] |
Inhibitor of nuclear factor kappa-B kinase subunit beta (IKBKB)
|
OT9RDS3H
|
IKKB_HUMAN
|
Decreases Activity
|
[53] |
Proepiregulin (EREG)
|
OTRM4NQY
|
EREG_HUMAN
|
Increases Expression
|
[54] |
Baculoviral IAP repeat-containing protein 5 (BIRC5)
|
OTILXZYL
|
BIRC5_HUMAN
|
Decreases Expression
|
[55] |
ATP-binding cassette sub-family C member 4 (ABCC4)
|
OTO27PAL
|
MRP4_HUMAN
|
Increases Expression
|
[31] |
ATP-binding cassette sub-family C member 5 (ABCC5)
|
OT34G4US
|
MRP5_HUMAN
|
Increases Expression
|
[31] |
CASP8 and FADD-like apoptosis regulator (CFLAR)
|
OTX14BAS
|
CFLAR_HUMAN
|
Increases Expression
|
[52] |
Bcl-2-like protein 11 (BCL2L11)
|
OTNQQWFJ
|
B2L11_HUMAN
|
Increases Expression
|
[56] |
Phospholipid-transporting ATPase ABCA1 (ABCA1)
|
OT94G6BQ
|
ABCA1_HUMAN
|
Decreases Expression
|
[57] |
Serine/threonine-protein kinase Chk2 (CHEK2)
|
OT8ZPCNS
|
CHK2_HUMAN
|
Increases Expression
|
[52] |
Ornithine transcarbamylase, mitochondrial (OTC)
|
OTJ57GGA
|
OTC_HUMAN
|
Decreases Expression
|
[58] |
Prothrombin (F2)
|
OTNFSM49
|
THRB_HUMAN
|
Affects Cleavage
|
[59] |
Renin (REN)
|
OT52GZR2
|
RENI_HUMAN
|
Decreases Activity
|
[60] |
Angiotensinogen (AGT)
|
OTBZLYR3
|
ANGT_HUMAN
|
Affects Activity
|
[61] |
Metalloproteinase inhibitor 1 (TIMP1)
|
OTOXC51H
|
TIMP1_HUMAN
|
Increases Expression
|
[62] |
Protein c-Fos (FOS)
|
OTJBUVWS
|
FOS_HUMAN
|
Decreases Expression
|
[52] |
Insulin-like growth factor II (IGF2)
|
OTJ4O6MW
|
IGF2_HUMAN
|
Decreases Expression
|
[63] |
Interleukin-1 alpha (IL1A)
|
OTPSGILV
|
IL1A_HUMAN
|
Increases Expression
|
[54] |
Fibrinogen alpha chain (FGA)
|
OTMIHY80
|
FIBA_HUMAN
|
Decreases Secretion
|
[64] |
Fibrinogen beta chain (FGB)
|
OT6RKLI9
|
FIBB_HUMAN
|
Decreases Secretion
|
[64] |
Albumin (ALB)
|
OTVMM513
|
ALBU_HUMAN
|
Decreases Secretion
|
[64] |
RAF proto-oncogene serine/threonine-protein kinase (RAF1)
|
OT51LSFO
|
RAF1_HUMAN
|
Decreases Expression
|
[52] |
Receptor tyrosine-protein kinase erbB-2 (ERBB2)
|
OTOAUNCK
|
ERBB2_HUMAN
|
Decreases Expression
|
[65] |
Cellular tumor antigen p53 (TP53)
|
OTIE1VH3
|
P53_HUMAN
|
Increases Acetylation
|
[66] |
Interleukin-4 (IL4)
|
OTOXBWAU
|
IL4_HUMAN
|
Decreases Expression
|
[67] |
Interleukin-6 (IL6)
|
OTUOSCCU
|
IL6_HUMAN
|
Decreases Expression
|
[14] |
Intercellular adhesion molecule 1 (ICAM1)
|
OTTOIX77
|
ICAM1_HUMAN
|
Decreases Expression
|
[68] |
Protein kinase C beta type (PRKCB)
|
OTYQ0656
|
KPCB_HUMAN
|
Affects Expression
|
[69] |
Retinoblastoma-associated protein (RB1)
|
OTQJUJMZ
|
RB_HUMAN
|
Decreases Expression
|
[70] |
Calpain-1 catalytic subunit (CAPN1)
|
OTK6OQZR
|
CAN1_HUMAN
|
Increases Expression
|
[71] |
Tumor necrosis factor receptor superfamily member 16 (NGFR)
|
OTPKSM49
|
TNR16_HUMAN
|
Increases Expression
|
[72] |
72 kDa type IV collagenase (MMP2)
|
OT5NIWA2
|
MMP2_HUMAN
|
Decreases Secretion
|
[62] |
Apolipoprotein(a) (LPA)
|
OTRZLU9F
|
APOA_HUMAN
|
Decreases Expression
|
[73] |
Hepatocyte growth factor receptor (MET)
|
OT7K55MU
|
MET_HUMAN
|
Increases Expression
|
[54] |
Heme oxygenase 1 (HMOX1)
|
OTC1W6UX
|
HMOX1_HUMAN
|
Increases Expression
|
[74] |
Poly polymerase 1 (PARP1)
|
OT310QSG
|
PARP1_HUMAN
|
Increases Cleavage
|
[75] |
Apoptosis regulator Bcl-2 (BCL2)
|
OT9DVHC0
|
BCL2_HUMAN
|
Decreases Expression
|
[53] |
Medium-chain specific acyl-CoA dehydrogenase, mitochondrial (ACADM)
|
OTA4P0FC
|
ACADM_HUMAN
|
Increases Expression
|
[76] |
Glucose-6-phosphate 1-dehydrogenase (G6PD)
|
OT300SMK
|
G6PD_HUMAN
|
Decreases Activity
|
[77] |
Cyclin-dependent kinase 4 (CDK4)
|
OT7EP05T
|
CDK4_HUMAN
|
Decreases Expression
|
[52] |
Granzyme A (GZMA)
|
OT43R33L
|
GRAA_HUMAN
|
Decreases Expression
|
[52] |
Cadherin-1 (CDH1)
|
OTFJMXPM
|
CADH1_HUMAN
|
Affects Methylation
|
[78] |
Xaa-Pro dipeptidase (PEPD)
|
OT3LFY7S
|
PEPD_HUMAN
|
Increases Activity
|
[79] |
Glial fibrillary acidic protein (GFAP)
|
OTQ01ZAS
|
GFAP_HUMAN
|
Decreases Expression
|
[80] |
L-selectin (SELL)
|
OT6RAJZR
|
LYAM1_HUMAN
|
Decreases Expression
|
[81] |
Sucrase-isomaltase, intestinal (SI)
|
OTUP724T
|
SUIS_HUMAN
|
Increases Activity
|
[63] |
Protein C-ets-2 (ETS2)
|
OTPVHOZ7
|
ETS2_HUMAN
|
Decreases Expression
|
[52] |
Fos-related antigen 1 (FOSL1)
|
OT9YTYMB
|
FOSL1_HUMAN
|
Decreases Expression
|
[82] |
Transcription factor 4 (TCF4)
|
OTB9ASTK
|
ITF2_HUMAN
|
Decreases Activity
|
[83] |
CD44 antigen (CD44)
|
OT9TTJ41
|
CD44_HUMAN
|
Decreases Expression
|
[84] |
Histone H2AX (H2AX)
|
OT18UX57
|
H2AX_HUMAN
|
Decreases Expression
|
[85] |
P-selectin (SELP)
|
OTWR90PK
|
LYAM3_HUMAN
|
Decreases Expression
|
[86] |
Platelet glycoprotein 4 (CD36)
|
OT5CZWKY
|
CD36_HUMAN
|
Decreases Expression
|
[86] |
Tumor necrosis factor receptor superfamily member 1A (TNFRSF1A)
|
OT2D9DOV
|
TNR1A_HUMAN
|
Increases Expression
|
[52] |
Bone morphogenetic protein 6 (BMP6)
|
OT9WN536
|
BMP6_HUMAN
|
Increases Expression
|
[54] |
G1/S-specific cyclin-D1 (CCND1)
|
OT8HPTKJ
|
CCND1_HUMAN
|
Decreases Expression
|
[87] |
Growth arrest and DNA damage-inducible protein GADD45 alpha (GADD45A)
|
OTDRV63V
|
GA45A_HUMAN
|
Increases Expression
|
[11] |
G1/S-specific cyclin-E1 (CCNE1)
|
OTLD7UID
|
CCNE1_HUMAN
|
Decreases Expression
|
[52] |
Cyclin-dependent kinase 2 (CDK2)
|
OTB5DYYZ
|
CDK2_HUMAN
|
Decreases Expression
|
[52] |
N-formyl peptide receptor 2 (FPR2)
|
OTEZ2THZ
|
FPR2_HUMAN
|
Increases Expression
|
[88] |
Proteinase-activated receptor 1 (F2R)
|
OT4WVWBO
|
PAR1_HUMAN
|
Decreases Expression
|
[86] |
Tumor necrosis factor receptor superfamily member 6 (FAS)
|
OTP9XG86
|
TNR6_HUMAN
|
Increases Expression
|
[52] |
NF-kappa-B inhibitor alpha (NFKBIA)
|
OTFT924M
|
IKBA_HUMAN
|
Decreases Expression
|
[52] |
Protein S100-A4 (S100A4)
|
OTLRGFSQ
|
S10A4_HUMAN
|
Decreases Expression
|
[52] |
Mitogen-activated protein kinase 3 (MAPK3)
|
OTCYKGKO
|
MK03_HUMAN
|
Decreases Expression
|
[89] |
Phosphatidylinositol 3-kinase regulatory subunit alpha (PIK3R1)
|
OT5BZ1J9
|
P85A_HUMAN
|
Decreases Expression
|
[52] |
Mitogen-activated protein kinase 1 (MAPK1)
|
OTH85PI5
|
MK01_HUMAN
|
Decreases Expression
|
[89] |
CD40 ligand (CD40LG)
|
OT75Z6A6
|
CD40L_HUMAN
|
Decreases Expression
|
[86] |
M-phase inducer phosphatase 1 (CDC25A)
|
OTSLKKCO
|
MPIP1_HUMAN
|
Decreases Expression
|
[52] |
RAC-alpha serine/threonine-protein kinase (AKT1)
|
OT8H2YY7
|
AKT1_HUMAN
|
Increases Expression
|
[52] |
Multidrug resistance-associated protein 1 (ABCC1)
|
OTGUN89S
|
MRP1_HUMAN
|
Increases Expression
|
[31] |
Catenin beta-1 (CTNNB1)
|
OTZ932A3
|
CTNB1_HUMAN
|
Decreases Localization
|
[84] |
Serpin B5 (SERPINB5)
|
OTSMXQRJ
|
SPB5_HUMAN
|
Increases Expression
|
[90] |
Peroxisome proliferator-activated receptor gamma (PPARG)
|
OTHMARHO
|
PPARG_HUMAN
|
Increases Expression
|
[51] |
Breast cancer type 1 susceptibility protein (BRCA1)
|
OT5BN6VH
|
BRCA1_HUMAN
|
Decreases Expression
|
[52] |
Cyclin-dependent kinase inhibitor 1 (CDKN1A)
|
OTQWHCZE
|
CDN1A_HUMAN
|
Decreases Expression
|
[52] |
Interleukin-6 receptor subunit beta (IL6ST)
|
OT1N9C70
|
IL6RB_HUMAN
|
Decreases Expression
|
[14] |
Caspase-3 (CASP3)
|
OTIJRBE7
|
CASP3_HUMAN
|
Increases Activity
|
[91] |
CD151 antigen (CD151)
|
OTF3UZS7
|
CD151_HUMAN
|
Decreases Expression
|
[37] |
Glycogen synthase kinase-3 beta (GSK3B)
|
OTL3L14B
|
GSK3B_HUMAN
|
Decreases Activity
|
[92] |
Carnitine O-palmitoyltransferase 1, liver isoform (CPT1A)
|
OTI862QH
|
CPT1A_HUMAN
|
Increases Expression
|
[76] |
Tumor necrosis factor ligand superfamily member 10 (TNFSF10)
|
OT4PXBTA
|
TNF10_HUMAN
|
Increases Response To Substance
|
[93] |
C-C chemokine receptor type 3 (CCR3)
|
OT6GBUFA
|
CCR3_HUMAN
|
Increases Expression
|
[94] |
Mitogen-activated protein kinase 12 (MAPK12)
|
OTTCKE27
|
MK12_HUMAN
|
Decreases Expression
|
[11] |
Microsomal triglyceride transfer protein large subunit (MTTP)
|
OTNUVSDT
|
MTP_HUMAN
|
Decreases Expression
|
[95] |
Caspase-9 (CASP9)
|
OTD4RFFG
|
CASP9_HUMAN
|
Increases Activity
|
[91] |
BH3-interacting domain death agonist (BID)
|
OTOSHSHU
|
BID_HUMAN
|
Increases Cleavage
|
[96] |
Small ribosomal subunit protein eS6 (RPS6)
|
OTT4D1LN
|
RS6_HUMAN
|
Decreases Phosphorylation
|
[85] |
Dermcidin (DCD)
|
OTV5PBGJ
|
DCD_HUMAN
|
Decreases Secretion
|
[64] |
Tumor necrosis factor-inducible gene 6 protein (TNFAIP6)
|
OT1SLUZH
|
TSG6_HUMAN
|
Decreases Expression
|
[54] |
Heat shock factor protein 1 (HSF1)
|
OTYNJ4KP
|
HSF1_HUMAN
|
Increases Activity
|
[97] |
E3 ubiquitin-protein ligase Mdm2 (MDM2)
|
OTOVXARF
|
MDM2_HUMAN
|
Decreases Expression
|
[52] |
Transcription factor E2F1 (E2F1)
|
OTLKYBBC
|
E2F1_HUMAN
|
Decreases Expression
|
[52] |
Dual specificity mitogen-activated protein kinase kinase 1 (MAP2K1)
|
OT4Y9NQI
|
MP2K1_HUMAN
|
Increases Expression
|
[52] |
Cytochrome P450 4A11 (CYP4A11)
|
OTPU5J0S
|
CP4AB_HUMAN
|
Affects Activity
|
[98] |
Peroxisome proliferator-activated receptor delta (PPARD)
|
OTI4WTOP
|
PPARD_HUMAN
|
Increases Expression
|
[99] |
Urokinase plasminogen activator surface receptor (PLAUR)
|
OTIRKKEQ
|
UPAR_HUMAN
|
Increases Expression
|
[100] |
Transcription factor p65 (RELA)
|
OTUJP9CN
|
TF65_HUMAN
|
Increases Localization
|
[101] |
Protein kinase C delta type (PRKCD)
|
OTSEH90E
|
KPCD_HUMAN
|
Increases Cleavage
|
[75] |
Apoptosis regulator BAX (BAX)
|
OTAW0V4V
|
BAX_HUMAN
|
Decreases Expression
|
[52] |
Bcl-2-like protein 1 (BCL2L1)
|
OTRC5K9O
|
B2CL1_HUMAN
|
Increases Expression
|
[102] |
Induced myeloid leukemia cell differentiation protein Mcl-1 (MCL1)
|
OT2YYI1A
|
MCL1_HUMAN
|
Decreases Expression
|
[56] |
Peroxisome proliferator-activated receptor alpha (PPARA)
|
OTK095PP
|
PPARA_HUMAN
|
Increases Expression
|
[51] |
Peroxisomal bifunctional enzyme (EHHADH)
|
OTBAAHL5
|
ECHP_HUMAN
|
Decreases Expression
|
[95] |
Interleukin-24 (IL24)
|
OT4VUWH1
|
IL24_HUMAN
|
Increases Expression
|
[54] |
Acetyl-CoA carboxylase 1 (ACACA)
|
OT5CQPZY
|
ACACA_HUMAN
|
Increases Expression
|
[76] |
5'-AMP-activated protein kinase catalytic subunit alpha-1 (PRKAA1)
|
OT7TNF0L
|
AAPK1_HUMAN
|
Increases Expression
|
[76] |
Serine-protein kinase ATM (ATM)
|
OTQVOHLT
|
ATM_HUMAN
|
Increases Expression
|
[52] |
Serine/threonine-protein kinase ATR (ATR)
|
OTH0OP1J
|
ATR_HUMAN
|
Decreases Expression
|
[11] |
Caspase-8 (CASP8)
|
OTA8TVI8
|
CASP8_HUMAN
|
Increases Expression
|
[52] |
Bcl-2 homologous antagonist/killer (BAK1)
|
OTDP6ILW
|
BAK_HUMAN
|
Increases Expression
|
[103] |
Scavenger receptor class B member 1 (SCARB1)
|
OTAE1UA1
|
SCRB1_HUMAN
|
Decreases Expression
|
[57] |
Bcl2-associated agonist of cell death (BAD)
|
OT63ERYM
|
BAD_HUMAN
|
Decreases Expression
|
[52] |
Tumor necrosis factor receptor superfamily member 25 (TNFRSF25)
|
OTVZ7I3A
|
TNR25_HUMAN
|
Increases Expression
|
[52] |
Bcl-2-modifying factor (BMF)
|
OT90NSLI
|
BMF_HUMAN
|
Increases Expression
|
[56] |
Bcl-2-binding component 3, isoforms 3/4 (BBC3)
|
OTUAXDAY
|
BBC3B_HUMAN
|
Increases Expression
|
[56] |
Diablo IAP-binding mitochondrial protein (DIABLO)
|
OTHJ9MCZ
|
DBLOH_HUMAN
|
Decreases Expression
|
[96] |
Gastrokine-1 (GKN1)
|
OT7ZYFQ9
|
GKN1_HUMAN
|
Affects Expression
|
[104] |
Mammalian ependymin-related protein 1 (EPDR1)
|
OT5JW5RB
|
EPDR1_HUMAN
|
Decreases Expression
|
[52] |
Cystine/glutamate transporter (SLC7A11)
|
OTKJ6PXW
|
XCT_HUMAN
|
Increases Expression
|
[54] |
Cysteinyl leukotriene receptor 1 (CYSLTR1)
|
OT904HBN
|
CLTR1_HUMAN
|
Increases Expression
|
[105] |
Kinesin-like protein KIF3A (KIF3A)
|
OTMUBSSK
|
KIF3A_HUMAN
|
Increases Expression
|
[106] |
Angiopoietin-related protein 3 (ANGPTL3)
|
OTCD5Z9W
|
ANGL3_HUMAN
|
Decreases Expression
|
[95] |
Interleukin-1 receptor type 2 (IL1R2)
|
OT0G7E35
|
IL1R2_HUMAN
|
Affects Response To Substance
|
[107] |
Prostaglandin E2 receptor EP2 subtype (PTGER2)
|
OT1AUZAA
|
PE2R2_HUMAN
|
Affects Response To Substance
|
[108] |
Voltage-dependent calcium channel gamma-6 subunit (CACNG6)
|
OT2PC1E1
|
CCG6_HUMAN
|
Affects Response To Substance
|
[109] |
Glutamate receptor 3 (GRIA3)
|
OT34CNBR
|
GRIA3_HUMAN
|
Increases ADR
|
[110] |
T-box transcription factor TBX21 (TBX21)
|
OT3UK5KE
|
TBX21_HUMAN
|
Affects Response To Substance
|
[111] |
Tumor necrosis factor (TNF)
|
OT4IE164
|
TNFA_HUMAN
|
Affects Response To Substance
|
[33] |
Platelet glycoprotein VI (GP6)
|
OT4IE8DV
|
GPVI_HUMAN
|
Decreases Response To Substance
|
[112] |
Platelet glycoprotein Ib alpha chain (GP1BA)
|
OT62PSOB
|
GP1BA_HUMAN
|
Increases Response To Substance
|
[113] |
Toll-like receptor 3 (TLR3)
|
OT8QPYXZ
|
TLR3_HUMAN
|
Affects Response To Substance
|
[114] |
Indoleamine 2,3-dioxygenase 1 (IDO1)
|
OT91DBN7
|
I23O1_HUMAN
|
Affects Response To Substance
|
[107] |
Histamine N-methyltransferase (HNMT)
|
OT9F303M
|
HNMT_HUMAN
|
Affects Response To Substance
|
[33] |
Pikachurin (EGFLAM)
|
OTACZZJ0
|
EGFLA_HUMAN
|
Increases ADR
|
[43] |
Regulator of G-protein signaling 7-binding protein (RGS7BP)
|
OTAGSWMH
|
R7BP_HUMAN
|
Affects Response To Substance
|
[115] |
Thromboxane-A synthase (TBXAS1)
|
OTAXZJJ4
|
THAS_HUMAN
|
Affects Response To Substance
|
[116] |
Interleukin-18 (IL18)
|
OTBB2A8O
|
IL18_HUMAN
|
Affects Response To Substance
|
[117] |
Serine/threonine-protein kinase 10 (STK10)
|
OTC33Y2F
|
STK10_HUMAN
|
Affects Response To Substance
|
[118] |
Cocaine esterase (CES2)
|
OTC647SQ
|
EST2_HUMAN
|
Increases Hydrolysis
|
[119] |
Prostaglandin D2 receptor 2 (PTGDR2)
|
OTCSMVF1
|
PD2R2_HUMAN
|
Affects Response To Substance
|
[33] |
Angiotensin-converting enzyme (ACE)
|
OTDF1964
|
ACE_HUMAN
|
Affects Response To Substance
|
[120] |
Apolipoprotein E (APOE)
|
OTFOWL2H
|
APOE_HUMAN
|
Affects Response To Substance
|
[121] |
Solute carrier family 22 member 2 (SLC22A2)
|
OTGFK1AL
|
S22A2_HUMAN
|
Affects Response To Substance
|
[122] |
Cytochrome P450 2C9 (CYP2C9)
|
OTGLBN29
|
CP2C9_HUMAN
|
Decreases Metabolism
|
[123] |
Bis(5'-adenosyl)-triphosphatase (FHIT)
|
OTGWBSLA
|
FHIT_HUMAN
|
Increases ADR
|
[43] |
Prostaglandin G/H synthase 1 (PTGS1)
|
OTHCRLEC
|
PGH1_HUMAN
|
Decreases Response To Substance
|
[112] |
Adenosine receptor A3 (ADORA3)
|
OTHO1BLK
|
AA3R_HUMAN
|
Affects Response To Substance
|
[124] |
Interleukin-13 (IL13)
|
OTI4YS3Y
|
IL13_HUMAN
|
Affects Response To Substance
|
[125] |
Adenosine receptor A1 (ADORA1)
|
OTI7X39E
|
AA1R_HUMAN
|
Affects Response To Substance
|
[126] |
Leucine-rich melanocyte differentiation-associated protein (LRMDA)
|
OTIPNKTU
|
LRMDA_HUMAN
|
Increases ADR
|
[34] |
Interleukin-10 (IL10)
|
OTIRFRXC
|
IL10_HUMAN
|
Increases Response To Substance
|
[127] |
High affinity immunoglobulin epsilon receptor subunit alpha (FCER1A)
|
OTIRUOHF
|
FCERA_HUMAN
|
Affects Response To Substance
|
[33] |
Sodium- and chloride-dependent betaine transporter (SLC6A12)
|
OTKOR4F2
|
S6A12_HUMAN
|
Affects Response To Substance
|
[128] |
High affinity immunoglobulin epsilon receptor subunit beta (MS4A2)
|
OTMCAS2D
|
FCERB_HUMAN
|
Affects Response To Substance
|
[129] |
Insulin receptor substrate 1 (IRS1)
|
OTNO82CU
|
IRS1_HUMAN
|
Affects Response To Substance
|
[16] |
Myeloperoxidase (MPO)
|
OTOOXLIN
|
PERM_HUMAN
|
Increases ADR
|
[17] |
Integrin alpha-2 (ITGA2)
|
OTPFL017
|
ITA2_HUMAN
|
Decreases Response To Substance
|
[130] |
Stromal membrane-associated protein 2 (SMAP2)
|
OTPGVRKO
|
SMAP2_HUMAN
|
Affects Response To Substance
|
[131] |
Growth arrest-specific protein 6 (GAS6)
|
OTPOPUUE
|
GAS6_HUMAN
|
Affects Response To Substance
|
[132] |
Prostaglandin E synthase 3 (PTGES3)
|
OTPPQWI0
|
TEBP_HUMAN
|
Increases ADR
|
[17] |
Glutamate receptor ionotropic, kainate 2 (GRIK2)
|
OTQ41U3D
|
GRIK2_HUMAN
|
Increases ADR
|
[110] |
Inosine triphosphate pyrophosphatase (ITPA)
|
OTQ47WVR
|
ITPA_HUMAN
|
Increases ADR
|
[133] |
Prostaglandin E2 receptor EP3 subtype (PTGER3)
|
OTQODQUN
|
PE2R3_HUMAN
|
Affects Response To Substance
|
[134] |
P2Y purinoceptor 1 (P2RY1)
|
OTR2KQ6Q
|
P2RY1_HUMAN
|
Decreases Response To Substance
|
[135] |
HLA class II histocompatibility antigen, DRB1 beta chain (HLA-DRB1)
|
OTRGGIFP
|
DRB1_HUMAN
|
Affects Response To Substance
|
[33] |
Cysteinyl leukotriene receptor 2 (CYSLTR2)
|
OTRNEOZ0
|
CLTR2_HUMAN
|
Affects Response To Substance
|
[33] |
Disintegrin and metalloproteinase domain-containing protein 33 (ADAM33)
|
OTRZVI77
|
ADA33_HUMAN
|
Affects Response To Substance
|
[136] |
Glutathione S-transferase Mu 1 (GSTM1)
|
OTSBF2MO
|
GSTM1_HUMAN
|
Affects Response To Substance
|
[137] |
Beta-2 adrenergic receptor (ADRB2)
|
OTSDOX4Q
|
ADRB2_HUMAN
|
Affects Response To Substance
|
[138] |
Lymphotoxin-alpha (LTA)
|
OTUC3S76
|
TNFB_HUMAN
|
Affects Response To Substance
|
[139] |
Adenosine receptor A2a (ADORA2A)
|
OTVRBZ0I
|
AA2AR_HUMAN
|
Affects Response To Substance
|
[126] |
Broad substrate specificity ATP-binding cassette transporter ABCG2 (ABCG2)
|
OTW8V2V1
|
ABCG2_HUMAN
|
Increases ADR
|
[140] |
Antigen peptide transporter 2 (TAP2)
|
OTWSYFI7
|
TAP2_HUMAN
|
Affects Response To Substance
|
[141] |
Prostacyclin receptor (PTGIR)
|
OTWTABYM
|
PI2R_HUMAN
|
Affects Response To Substance
|
[33] |
Interleukin-17A (IL17A)
|
OTY72FT2
|
IL17_HUMAN
|
Affects Response To Substance
|
[125] |
Fibrous sheath-interacting protein 1 (FSIP1)
|
OTYLL6GM
|
FSIP1_HUMAN
|
Affects Response To Substance
|
[142] |
Galectin-10 (CLC)
|
OTYMYR85
|
LEG10_HUMAN
|
Affects Response To Substance
|
[143] |
Centrosomal protein of 68 kDa (CEP68)
|
OTZDM4J1
|
CEP68_HUMAN
|
Affects Response To Substance
|
[144] |
Cytochrome P450 2D6 (CYP2D6)
|
OTZJC802
|
CP2D6_HUMAN
|
Increases ADR
|
[145] |
NACHT, LRR and PYD domains-containing protein 3 (NLRP3)
|
OTZM6MHU
|
NLRP3_HUMAN
|
Affects Response To Substance
|
[146] |
------------------------------------------------------------------------------------ |
|
|
|
|